New FDA chief wants to transform treatment
WASHINGTON — The new acting chief of the Food and Drug Administration says he will be presiding over a transformation in medicine as scientists come to understand diseases in a more detailed way that could improve doctors' ability to treat patients.
By John J. Lumpkin, Associated Press
September 25, 2005